Annual report pursuant to Section 13 and 15(d)

Intangibles (Narrative) (Details)

v3.22.1
Intangibles (Narrative) (Details)
$ in Thousands
 12 Months Ended
Jan. 01, 2022
USD ($)
Jul. 01, 2021
USD ($)
Apr. 01, 2021
USD ($)
Mar. 13, 2021
USD ($)
Jan. 01, 2021
USD ($)
Dec. 18, 2020
USD ($)
installment
Jun. 29, 2020
USD ($)
Milestone
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Finite-Lived Intangible Assets [Line Items]                    
Purchase of intangible asset                 $ 400 $ 1,200
Journey [Member] | Dr. Reddy's Laboratories, Ltd [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Purchase of intangible asset             $ 5,000      
Payments of milestones             $ 4,000      
Asset Purchase Agreement, Agreement Term             10 years      
Asset Purchase Agreement, Period of written notice to terminate the agreement             180 days      
Achievement of Certain Sales Milestones [Member] | Journey [Member] | Dr. Reddy's Laboratories, Ltd [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Payments of milestones             $ 17,000      
Number of development milestones | Milestone             3      
Payable within 60 Days After Execution [Member] | Journey [Member] | Dr. Reddy's Laboratories, Ltd [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Payment of Upfront Fees             $ 1,000      
Minimum [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Intangible assets, estimated useful lives                 3 years  
Maximum [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Intangible assets, estimated useful lives                 7 years  
Anti-itch Product [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Intangible assets, estimated useful lives           3 years        
Number of installments to pay the upfront fees | installment           3        
Asset purchase agreement, non refundable deposit           $ 200        
Initial discount for imputed interest           100        
Anti-itch Product [Member] | Journey [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Purchase of intangible asset           4,000        
Payment of Upfront Fees         $ 1,800          
Payments of milestones   $ 500 $ 500              
Asset purchase agreement, non refundable deposit           $ 200        
Anti-itch Product [Member] | Scenario, Plan [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Installment payment related to intangible asset               $ 1,000 $ 2,800  
Anti-itch Product [Member] | Scenario, Plan [Member] | Journey [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Payments of milestones $ 1,000             $ 0    
Oral Acne Product (Isotretinoin) [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Asset Purchase Agreement Upfront Payment To Be Made             1,000      
Number of installments to pay the upfront fees | installment           3        
Installment payment related to intangible asset           $ 3,500 500      
Initial discount for imputed interest             $ 300      
Qbrexza [Member] | Journey [Member] | Dermira, Inc. a subsidiary of Eli Lilly [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Purchase of intangible asset       $ 12,500            
Payment of Upfront Fees       $ 12,500            
Percentage of royalty amounts diminution in the event of loss of exclusivity       50.00%            
Intangible assets, amortization period       7 years            
Qbrexza [Member] | Achievement of Certain Sales Milestones [Member] | Journey [Member] | Dermira, Inc. a subsidiary of Eli Lilly [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Payments of milestones       $ 144,000            
Qbrexza [Member] | Minimum [Member] | First Two Years [Member] | Journey [Member] | Dermira, Inc. a subsidiary of Eli Lilly [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Asset purchase agreement, percentage of royalties       30.00%            
Qbrexza [Member] | Minimum [Member] | Period of Eight Years, After First Two Years [Member] | Journey [Member] | Dermira, Inc. a subsidiary of Eli Lilly [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Asset purchase agreement, percentage of royalties       12.00%            
Qbrexza [Member] | Maximum [Member] | First Two Years [Member] | Journey [Member] | Dermira, Inc. a subsidiary of Eli Lilly [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Asset purchase agreement, percentage of royalties       40.00%            
Qbrexza [Member] | Maximum [Member] | Period of Eight Years, After First Two Years [Member] | Journey [Member] | Dermira, Inc. a subsidiary of Eli Lilly [Member]                    
Finite-Lived Intangible Assets [Line Items]                    
Asset purchase agreement, percentage of royalties       19.00%